Your browser doesn't support javascript.
loading
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.
Zhang, Xin; Xiao, Weiping; Zhang, Qing; Xia, Ding; Gao, Peng; Su, Jiabin; Yang, Heng; Gao, Xinjie; Ni, Wei; Lei, Yu; Gu, Yuxiang.
Affiliation
  • Zhang X; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Xiao W; Neurosurgical Institute of Fudan University, Shanghai, China.
  • Zhang Q; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
  • Xia D; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China.
  • Gao P; Department of Neurosurgery, Huashan Hospital North, Fudan University, Shanghai, China.
  • Su J; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yang H; Neurosurgical Institute of Fudan University, Shanghai, China.
  • Gao X; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
  • Ni W; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China.
  • Lei Y; Department of Neurosurgery, Huashan Hospital North, Fudan University, Shanghai, China.
  • Gu Y; Department of Nursing, Huashan Hospital North, Fudan University, Shanghai, China.
Curr Neuropharmacol ; 20(2): 292-308, 2022.
Article in En | MEDLINE | ID: mdl-34279201
ABSTRACT
Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral vascular network at the base of the brain. Its clinical manifestations are complicated. Numerous studies have attempted to clarify the clinical features of MMD, including its epidemiology, genetic characteristics, and pathophysiology. With the development of neuroimaging techniques, various neuroimaging modalities with different advantages have deepened the understanding of MMD in terms of structural, functional, spatial, and temporal dimensions. At present, the main treatment for MMD focuses on neurological protection, cerebral blood flow reconstruction, and neurological rehabilitation, such as pharmacological treatment, surgical revascularization, and cognitive rehabilitation. In this review, we discuss recent progress in understanding the clinical features, in the neuroimaging evaluation and treatment of MMD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Moyamoya Disease Limits: Humans Language: En Journal: Curr Neuropharmacol Year: 2022 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Moyamoya Disease Limits: Humans Language: En Journal: Curr Neuropharmacol Year: 2022 Document type: Article Affiliation country: China